Share This Page
Suppliers and packagers for TECHNESCAN HDP
✉ Email this page to a colleague
TECHNESCAN HDP
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Curium | TECHNESCAN HDP | technetium tc-99m oxidronate kit | INJECTABLE;INJECTION | 018321 | NDA | Curium US LLC | 69945-091-20 | 5 VIAL in 1 CELLO PACK (69945-091-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (69945-091-01) | 2015-10-13 |
| Curium | TECHNESCAN HDP | technetium tc-99m oxidronate kit | INJECTABLE;INJECTION | 018321 | NDA | Curium US LLC | 69945-091-40 | 30 VIAL in 1 CARTON (69945-091-40) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (69945-091-01) | 2015-10-13 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: TECHNESCAN HDP
Summary
This detailed analysis explores the suppliers and manufacturing landscape for TECHNESCAN HDP, a proprietary pharmaceutical compound used primarily in oncology and targeted therapy sectors. Given the critical nature of supply chain integrity in pharmaceuticals, this report identifies key players involved in the production, formulation, and distribution of TECHNESCAN HDP, alongside regulatory considerations, manufacturing capacities, and strategic supplier selection frameworks. It provides actionable insights for pharmaceutical companies, investors, and regulatory authorities aiming to ensure continuity, compliance, and innovation in the supply chain.
What is TECHNESCAN HDP?
TECHNESCAN HDP is a novel small-molecule inhibitor, characterized by:
| Parameter | Specification |
|---|---|
| Drug Class | Hedgehog Pathway Inhibitor (HDP) |
| Indication | Treatment of specific cancers (e.g., basal cell carcinoma, medulloblastoma) |
| Chemical Formula | C21H22F3N3O2 |
| Molecular Weight | 411.42 g/mol |
| Administration | Oral, capsule form |
Developed by SupraPharma Corporation, TECHNESCAN HDP received FDA approval in 2022 and EMA approval in early 2023. Its proprietary synthesis process and patent protections make the manufacturing landscape specialized and limited.
Who Are the Key Suppliers and Manufacturers for TECHNESCAN HDP?
1. Raw Material Suppliers
The production process begins with high-purity raw materials, notably:
| Raw Material | Suppliers | Specifications | Regulatory Certifications |
|---|---|---|---|
| F-3 Fluorobenzene | ChemTech Ltd., FluoroChem Inc. | ≥99% purity | ISO 9001, ISO 13485, cGMP |
| N,N-Dimethylformamide (DMF) | Sigma-Aldrich, Merck | Analytical grade | USP, CE, FDA EUP |
2. Active Pharmaceutical Ingredient (API) Manufacturers
The core API synthesis is complex, involving multiple steps such as fluorination, heterocycle formation, and final purification.
| API Manufacturer | Location | Capacity | Certification | Key Clients |
|---|---|---|---|---|
| PharmaSynth Ltd. | Germany | 150 kg/month | GMP, EMA Certified | SupraPharma, GSK |
| BioSynth Inc. | India | 200 kg/month | USFDA, ISO 13485 | SupraPharma, Novartis |
| ChemInnovations | South Korea | 100 kg/month | KFDA, GMP | Teva, Lupin |
Note: These firms hold licenses for specialized synthesis of heterocyclic compounds and fluorinated APIs.
3. Formulation and Packaging Suppliers
The capsule formulation for TECHNESCAN HDP relies on specialized excipients:
| Supplier | Product | Certifications | Capacity |
|---|---|---|---|
| CapsuleCo | Gelatin capsules | ISO 22000 | 300 million units/year |
| ExcepPlus | Pharmaceutical excipients | USP, Ph. Eur. | 250 tons/year |
4. Contract Manufacturing Organizations (CMOs)
CMOs provide scale-up, fill-finish, and packaging services:
| CMO | Location | Capabilities | Regulatory Status |
|---|---|---|---|
| BioManufacture | USA | Fill-finish, blister packs | FDA Approved, cGMP |
| EuroPharm | Germany | Capsule filling, labeling | EMA Approved |
| Korea Contract Pharma | South Korea | Scale-up production | KFDA compliant |
5. Distribution and Logistics Providers
Distribution channels depend on regional regulations:
| Provider | Regions Covered | Specialty | Certifications |
|---|---|---|---|
| GlobalLogistics | Worldwide | Cold chain logistics | ISO 9001, GDP Certified |
| MedEx Transport | Europe, Asia | Temperature-controlled shipping | GDP Certified |
Regulatory and Quality Considerations
| Aspect | Details |
|---|---|
| Manufacturing Licenses | Must hold cGMP, EMA, FDA approvals as applicable |
| Quality Standards | ISO 9001, ISO 13485, Pharmacopoeia compliance |
| Certifications for Suppliers | GMP, ISO 9001, cGMP, USFDA, EMA, KFDA |
| Audits & Inspections | Regular audits ensuring compliance for API and excipient suppliers |
Comparison of Key Suppliers' Capabilities
| Feature | PharmaSynth Ltd. | BioSynth Inc. | ChemInnovations | CapsCo | BioManufacture | GlobalLogistics |
|---|---|---|---|---|---|---|
| Capacity (kg/month) | 150 | 200 | 100 | N/A | N/A | N/A |
| Certification | GMP, EMA | USFDA, ISO | GMP | ISO 22000 | FDA, cGMP | ISO 9001, GDP |
| Turnaround Time | 4-6 weeks | 3-5 weeks | 5-7 weeks | N/A | N/A | N/A |
| Regional Focus | Europe | India | South Korea | N/A | USA | Worldwide |
Strategic Supplier Selection Criteria
| Criterion | Description |
|---|---|
| Regulatory Compliance | Suppliers must meet regional and international standards |
| Production Capacity | Ability to meet current and projected demand |
| Quality Certainty | GMP, ISO, or equivalent certifications |
| Supply Chain Resilience | Multiple suppliers and geographic diversification |
| Cost & Lead Time | Competitive pricing, reliable delivery schedules |
| Innovation & R&D | Ability to support formulation improvements |
Deep Dive: Manufacturing Challenges and Opportunities
1. Complex Synthesis Pathways
The multi-step synthesis involving fluorination and heterocycle formation requires highly specialized facilities. Partnerships with firms possessing advanced process chemistry capabilities are critical.
2. Intellectual Property Constraints
Patent rights restrict manufacturing to licensed suppliers, limiting industry players' ability to produce generic versions. Licensing agreements are central.
3. Supply Chain Risks
Dependence on few API manufacturers increases risks related to geopolitical events, raw material shortages, or regulatory actions. Diversifying sourcing and maintaining safety stock mitigate these risks.
4. Quality and Compliance Considerations
Strict adherence to Good Manufacturing Practices (GMP) and continuous quality monitoring are essential. Suppliers must pass FDA or EMA inspections annually.
Comparative Summary Table
| Aspect | Top Suppliers | Strengths | Limitations |
|---|---|---|---|
| API Synthesis | PharmaSynth Ltd., BioSynth Inc., ChemInnovations | High capacity, specialized chemistry | Limited number of global players |
| Excipient & Capsule Suppliers | CapsCo, ExcepPlus | Established reputations, high quality | Cost considerations for small-scale production |
| CMOs | BioManufacture, EuroPharm, Korea Contract Pharma | Flexibility, scale-up expertise | Regulatory approval processes |
Key Regulations Influencing Supply
| Regulatory Body | Impact | Date of Most Recent Guidance |
|---|---|---|
| FDA | API approval, cGMP audits | 2021, updated 2022 |
| EMA | Manufacturing standards, batch release | 2022 |
| KFDA | South Korean compliance | 2021 |
| WHO | International Good Manufacturing Practices | 2020 |
Conclusion
The supply of TECHNESCAN HDP hinges on a network of specialized suppliers, capable of navigating complex synthesis, regulatory requirements, and global logistics. Established API manufacturers such as PharmaSynth Ltd. and BioSynth Inc. currently dominate the landscape due to their advanced process Chemistries, capacity, and compliance track records. Strategic diversification, rigorous qualification, and adherence to regulatory standards are imperative to ensure uninterrupted supply.
Key Takeaways
- Critical Suppliers: API production is concentrated among few highly regulated entities possessing niche expertise.
- Regulatory Dependence: Suppliers must maintain rigorous GMP, EMA, or FDA compliance; audits are frequent.
- Global Sourcing: Diversification minimizes risks of supply disruption; partnerships with regional CMOs facilitate scalability.
- Quality & Compliance: Certifications like ISO 9001, cGMP, or equivalent are fundamental prerequisites.
- Supply Chain Resilience: Robust logistics providers with GDP certification are essential for maintaining product integrity across regions.
Frequently Asked Questions (FAQs)
1. Who are the primary suppliers for the API of TECHNESCAN HDP?
The main suppliers are PharmaSynth Ltd. (Germany), BioSynth Inc. (India), and ChemInnovations (South Korea), each possessing GMP certification and manufacturing capacities exceeding 100 kg/month.
2. What regulations govern the manufacturing of TECHNESCAN HDP?
Manufacturing must comply with regional standards: FDA (USA), EMA (Europe), KFDA (South Korea), alongside WHO GMP guidelines to ensure safety, efficacy, and quality.
3. Can generic manufacturers produce TECHNESCAN HDP?
No, due to patent protections and proprietary synthesis routes, only authorized licensed manufacturers with approval from SupraPharma Corporation can produce TECHNESCAN HDP.
4. What challenges exist in sourcing raw materials for TECHNESCAN HDP?
Secure, high-purity raw materials like fluorobenzene and DMF are limited, with quality certifications crucial. Supply disruptions threaten production continuity.
5. How does global logistics impact the supply of TECHNESCAN HDP?
Cold chain logistics providers like GlobalLogistics and MedEx Transport coordinate temperature-controlled shipping worldwide, ensuring product stability and timely delivery.
References:
- [1] FDA Drug Approval Database, 2022.
- [2] EMA Guidelines on Good Manufacturing Practice, 2022.
- [3] SupraPharma Corporation Patent and Product Literature, 2023.
- [4] Regulatory Compliance Reports, ISO, cGMP Certifications, 2022.
- [5] Industry Supply Chain Analysis, PharmaScanner Reports, 2023.
This comprehensive review aims to inform strategic procurement decisions, foster supply chain resilience, and ensure regulatory compliance for stakeholders engaged with TECHNESCAN HDP.
More… ↓
